Market News

MindMed (NASDAQ: MNMD) Tanks After Public Offering

Shares of Mind Medicine (NASDAQ: MNMD) tanked in pre-market trading on Wednesday as the clinical-stage biopharmaceutical company announced a public offering of 7 million common shares along with warrants to purchase 7 million common shares.

MindMed has priced the combined offering of each common share and accompanying warrant at $4.25 per share. The accompanying warrant can be exercised immediately with an exercise price of $4.25 per share with an expiry of five years from the date of issuance.

The company expects gross proceeds of around $30 million and the offering is expected to close on and around September 30.

Is MindMed a Buy or Sell?

MindMed gets a Strong Buy consensus rating from Wall Street ratings based on four unanimous Buys. The average price forecast for MindMed stock is $32.88 implying an upside potential of 437.2%.

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More